Zhejiang AngLiKang PharmaceuticalLTD Balance Sheet Health
Financial Health criteria checks 5/6
Zhejiang AngLiKang PharmaceuticalLTD has a total shareholder equity of CN¥1.8B and total debt of CN¥565.1M, which brings its debt-to-equity ratio to 31.6%. Its total assets and total liabilities are CN¥3.1B and CN¥1.3B respectively. Zhejiang AngLiKang PharmaceuticalLTD's EBIT is CN¥159.3M making its interest coverage ratio -34.6. It has cash and short-term investments of CN¥894.8M.
Key information
31.6%
Debt to equity ratio
CN¥565.09m
Debt
| Interest coverage ratio | -34.6x |
| Cash | CN¥894.82m |
| Equity | CN¥1.79b |
| Total liabilities | CN¥1.29b |
| Total assets | CN¥3.08b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002940's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥932.2M).
Long Term Liabilities: 002940's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥362.5M).
Debt to Equity History and Analysis
Debt Level: 002940 has more cash than its total debt.
Reducing Debt: 002940's debt to equity ratio has increased from 0% to 31.6% over the past 5 years.
Debt Coverage: 002940's debt is well covered by operating cash flow (39.5%).
Interest Coverage: 002940 earns more interest than it pays, so coverage of interest payments is not a concern.